Yogesh S. Jethava
Elite in Multiple Myeloma

Dr. Yogesh S. Jethava

Hematology | Oncology
Aurora Healthcare
Advocate Medical Group Transplant And Cellular Therapy
1700 Luther Ln, Ste 1220, 
Park Ridge, IL 
On Staff At
Elite in Multiple Myeloma
Aurora Healthcare
Advocate Medical Group Transplant And Cellular Therapy
1700 Luther Ln, Ste 1220, 
Park Ridge, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yogesh Jethava is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. Jethava is rated as an Elite provider by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 20 articles and participated in 4 clinical trials in the study of Multiple Myeloma.

Residency
Mumbai University, Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in IN
Board Certifications
American Board Of Internal Medicine, Hematology
Fellowships
Guys, Kings and St Thomas' Hospital, Hematology/Oncology
Hospital Affiliations
Advocate Lutheran General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Advocate Medical Group Transplant and Cellular Therapy
1700 Luther Ln, Ste 1220, Park Ridge, IL 60068
Call: 847-723-4400

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Enrollment Status: Completed
Publish Date: October 21, 2025
Intervention Type: Drug, Other
Study Drug: Melphalan
Study Phase: Phase 1
A Phase 1 Study of SEA-BCMA in Patients With Relapsed or Refractory Multiple Myeloma
A Phase 1 Study of SEA-BCMA in Patients With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: December 24, 2024
Intervention Type: Drug
Study Drugs: SEA-BCMA, Dexamethasone, Pomalidomide
Study Phase: Phase 1
Single Autologous Transplant Followed by Consolidation and Maintenance for Participants ≥ 65 Years of Age Diagnosed With Multiple Myeloma or a Related Plasma Cell Malignancy
Single Autologous Transplant Followed by Consolidation and Maintenance for Participants ≥ 65 Years of Age Diagnosed With Multiple Myeloma or a Related Plasma Cell Malignancy
Enrollment Status: Completed
Publish Date: May 11, 2022
Intervention Type: Drug, Procedure
Study Phase: Phase 2
Phase 1 Study of SGN-CD352A in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Study of SGN-CD352A in Patients With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: August 12, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment Status: Terminated
Publish Date: December 12, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

35 Total Publications

Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.
Journal: Bone marrow transplantation
Published: August 07, 2023
View All 35 Publications
Similar Doctors
Elite in Multiple Myeloma
Dr. Andrzej J. Jakubowiak
Oncology | Hematology | Transplant Surgery
Elite in Multiple Myeloma
Dr. Andrzej J. Jakubowiak
Oncology | Hematology | Transplant Surgery

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (21.4 miles away)
773-702-1000
Languages Spoken:
English, Polish
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrzej Jakubowiak is an Oncologist and a Hematologist in Chicago, Illinois. Dr. Jakubowiak is rated as a Distinguished provider by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jakubowiak is currently accepting new patients.

Elite in Multiple Myeloma
Dr. Seema Singhal
Hematology
Elite in Multiple Myeloma
Dr. Seema Singhal
Hematology
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (15.7 miles away)
866-587-4322
Experience:
39+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Seema Singhal is a Hematologist in Chicago, Illinois. Dr. Singhal has been practicing medicine for over 39 years and is rated as a Distinguished provider by MediFind in the treatment of Multiple Myeloma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Elite in Multiple Myeloma
Dr. Benjamin A. Derman
Hematology Oncology | Hematology | Oncology
Elite in Multiple Myeloma
Dr. Benjamin A. Derman
Hematology Oncology | Hematology | Oncology

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (21.4 miles away)
773-702-1000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Benjamin Derman is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Derman is rated as a Distinguished provider by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, GTP Cyclohydrolase 1 Deficiency, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Derman is currently accepting new patients.

VIEW MORE MULTIPLE MYELOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jethava's expertise for a condition
ConditionClose
  • Elite
  • Multiple Myeloma
    Dr. Jethava is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Distinguished
  • Bone Marrow Transplant
    Dr. Jethava is
    Distinguished
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Smoldering Multiple Myeloma
    Dr. Jethava is
    Distinguished
    . Learn about Smoldering Multiple Myeloma.
    See more Smoldering Multiple Myeloma experts
  • Advanced
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Jethava is
    Advanced
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Jethava is
    Advanced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Jethava is
    Advanced
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Acute Myeloid Leukemia (AML)
    Dr. Jethava is
    Advanced
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Bone Marrow Aspiration
    Dr. Jethava is
    Advanced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Childhood Acute Myeloid Leukemia
    Dr. Jethava is
    Advanced
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
View All 14 Advanced Conditions
  • Experienced
  • Acute Myelomonocytic Leukemia
    Dr. Jethava is
    Experienced
    . Learn about Acute Myelomonocytic Leukemia.
    See more Acute Myelomonocytic Leukemia experts
  • Adult Soft Tissue Sarcoma
    Dr. Jethava is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Agranulocytosis
    Dr. Jethava is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anaplastic Large Cell Lymphoma
    Dr. Jethava is
    Experienced
    . Learn about Anaplastic Large Cell Lymphoma.
    See more Anaplastic Large Cell Lymphoma experts
  • Aplastic Anemia
    Dr. Jethava is
    Experienced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
  • Atypical Hemolytic Uremic Syndrome (aHUS)
    Dr. Jethava is
    Experienced
    . Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
    See more Atypical Hemolytic Uremic Syndrome (aHUS) experts
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.